Cargando…
Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
Osteoclasts are multinuclear giant cells that have unique ability to degrade bone. The search for new medicines that modulate the formation and function of osteoclasts is a potential approach for treating osteoclast-related bone diseases. Piceatannol (PIC) is a natural organic polyphenolic stilbene...
Autores principales: | Yan, Liuliu, Lu, Lulu, Hu, Fangbin, Shetti, Dattatrya, Wei, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599799/ https://www.ncbi.nlm.nih.gov/pubmed/31312498 http://dx.doi.org/10.1098/rsos.190360 |
Ejemplares similares
-
M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts
por: Hodge, Jason M., et al.
Publicado: (2011) -
Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption
por: Jang, Jin Sun, et al.
Publicado: (2019) -
Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption
por: McDonald, Michelle M., et al.
Publicado: (2021) -
Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption
por: McDonald, Michelle M., et al.
Publicado: (2021) -
ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
por: Liang, Xinyue, et al.
Publicado: (2021)